Tuberculosis and diabetes mellitus: the current state of the problem

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Certain successes have been achieved in the fight against tuberculosis (TB) in the Russian Federation in recent years. However, the current TB situation remains tense. A certain role in this has been played by the spread of nosological entities that also include diabetes mellitus (DM). The review presents data on the prevalence, the features of the course of TB and DM comorbidity, and the efficiency of its treatment.

Full Text

Restricted Access

About the authors

O. G. Komissarova

Central Research Institute of Tuberculosis; N.I. Pirogov National Research Medical University, Ministry of Health of Russia

Email: rizvan0403@yandex.ru
ORCID iD: 0000-0003-4427-3804

MD

Russian Federation, Moscow; Moscow

E. G. Polushkina

Central Research Institute of Tuberculosis

Email: rizvan0403@yandex.ru
Russian Federation, Moscow

R. Yu. Abdullaev

Central Research Institute of Tuberculosis

Author for correspondence.
Email: rizvan0403@yandex.ru
ORCID iD: 0000-0002-9105-9264

MD, Professor

Russian Federation, Moscow

References

  1. Васильева И.А., Тестов В.В., Стерликов А.С. Эпидемическая ситуация по туберкулезу в годы пандемии COVID-19 – 2020–2021 гг. Туберкулез и болезни легких. 2022; 100 (3): 6–12 [Vasilyeva I.А., Testov V.V., Sterlikov S.А. Tuberculosis situation in the years of the COVID-19 pandemic – 2020-2021. Tuberculosis and Lung Diseases. 2022; 100 (3): 6–12 (in Russ.)]. doi: 10.21292/2075-1230-2022-100-3-6-12
  2. Global Tuberculosis Report 2022. WHO, 2022. URL: https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2022
  3. Комиссарова О.Г., Абдуллаев Р.Ю., Алешина С.В. и др. Осложнения сахарного диабета при его сочетании с туберкулезом легких. Врач. 2019; 30 (7): 38–41 [Komissarova O., Abdullaev R., Aleshina S. et al. Complications of diabetes mellitus in its concurrence with pulmonary tuberculosis. Vrach. 2019; 30 (7): 38–41 (in Russ.)]. doi: 10.29296/25877305-2019-07-07
  4. IDF Diabetes Atlas, 10th edn. Brussels: International Diabetes Federation (IDF), 2021. URL: https://www.diabetesatlas.org
  5. Дедов И.И, Шестакова М.В., Викулова О.К. и др. Эпидемиологические характеристики сахарного диабета в российской федерации: клинико-статистический анализ по данным федерального регистра сахарного диабета на 01.01.2021. Сахарный диабет. 2021; 24 (3): 204–21 [Dedov I.I., Shestakova M.V., Vikulova O.K. et al. Epidemiological characteristics of diabetes mellitus in the Russian Federation: clinical and statistical analysis according to the Federal diabetes register data of 01.01.2021. Diabetes mellitus. 2021; 24 (3): 204–21 (in Russ.)]. doi: 10.14341/DM12759
  6. Goldhaber-Fiebert J.D., Jeon C. Y., Cohen T. et al. Diabetes mellitus and tuberculosis in countries with high tuberculosis burdens: Individual risks and social determinants. Int J Epidemiol. 2011; 40 (2): 417–28. doi: 10.1093/ije/dyq238
  7. Badawi A., Sayegh S., Sallam M. et al. The global relationship between the prevalence of diabetes mellitus and incidence of tuberculosis: 2000-2012. Glob J Health Sci. 2015; 7 (2): 183–91. doi: 10.5539/gjhs.v7n2p183
  8. Noubiap J.J., Nansseu J.R., Nyaga U.F. et al. Global prevalence of diabetes in active tuberculosis: a systematic review and meta-analysis of data from 2.3 million patients with tuberculosis. Lancet Glob Health. 2019; 7 (4): 448–60. doi: 10.1016/S2214-109X(18)30487-X
  9. Jeon C.Y., Harries A.D., Baker M.A. et al. Bi-directional screening for tuberculosis and diabetes: A systematic review. Trop Med Int Heal. 2010; 15 (11): 1300–14. doi: 10.1111/j.1365-3156.2010.02632.x
  10. Workneh M.H., Bjune G.A., Yimer S.A. Prevalence and associated factors of tuberculosis and diabetes mellitus comorbidity: A systematic review. PLoS One. 2017; 12 (4): 1–25. doi: 10.1371/journal.pone.0175925
  11. Dooley K.E., Chaisson R.E. Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis. 2009; 9 (12): 737–46. doi: 10.1016/S1473-3099(09)70282-8
  12. Oursler K.K., Moore R.D., Bishai W.R. et al. Survival of patients with pulmonary tuberculosis: clinical and molecular epidemiologic factors. Clin Infect Dis. 2002; 34 (6): 752–9. doi: 10.1086/338784
  13. Dooley K.E., Tang T., Golub J.E. et al. Impact of Diabetes Mellitus on Treatment Outcomes of Patients with Active Tuberculosis. The American. Am J Trop Med Hyg. 2009; 80 (4): 634–9.
  14. Baker M.A., Harries A.D., Jeon C.Y. et al. The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Med. 2011; 9: 81. doi: 10.1186/1741-7015-9-81
  15. Restrepo B.I., Fisher-Hoch S.P., Pino P.A. et al. Tuberculosis in poorly controlled type 2 diabetes: altered cytokine expression in peripheral white blood cells. Clin Infect Dis. 2008; 47 (5): 634–41. doi: 10.1086/590565
  16. Николаева О.Д. Результаты лечения больных туберкулезом легких с сопутствующими заболеваниями. Украинский пульмонологический журнал. 2005; 4: 14–6 [Nikolaevа O.D. The results of treatment of patients with pulmonary tuberculosis and concomitant diseases. Ukrainian Journal of Pulmonology. 2005; 4: 14–6 (in Russ.)].
  17. Смурова Т.Ф., Ковалева С.И. Туберкулез и сахарный диабет. М.: «Медкнига», 2007; с. 317 [Smurova T.F., Kovaleva S.I. Tuberkulez i sakharnyi diabet. M.: «Medkniga», 2007; s. 317 (in Russ.)].
  18. Карачунский М.А., Каминская Г.О., Коссий Ю.Е. и др. Туберкулез у больных сахарным диабетом – современные проблемы. Проблемы туберкулеза и болезней легких. 2006; 10: 17–9 [Karachunskii M.A., Kaminskaya G.O., Kossii Yu.E. et al. Tuberkulez u bol'nykh sakharnym diabetom – sovremennye problemy. Problemy tuberkuleza i boleznei legkikh. 2006; 10: 17–9 (in Russ.)].
  19. Елагина В.Ю. Клинические параллели развития туберкулеза легких и сахарного диабета. Бюллетень медицинских интернет-конференций. 2013; 3 (2): 416 [Elagina V.Yu. Klinicheskie paralleli razvitiya tuberkuleza legkikh i sakharnogo diabeta. Bulletin of Medical Internet Conferences. 2013; 3 (2): 416 (in Russ.)].
  20. Иванова З.А., Кошечкин В.А., Арсентьева Н.В. Течение туберкулеза легких у больных с сахарным диабетом. Современные наукоемкие технологии. 2005; 10: 43 [Ivanova Z.A., Koshechkin V.A., Arsentieva N.V. Lung tuberculosis and diabetes mellitus. Modern high technologies. 2005; 10: 43 (in Russ.)].
  21. Хадиуллина Л.Ф., Моругова Т.В. Распространенность и клинические особенности туберкулеза на фоне сахарного диабета. Мат-лы VII Всеросс. диабетологического конгр. 2015; 1: 32 [Khadiullina L.F., Morugova T.V. Rasprostranennost' i klinicheskie osobennosti tuberkuleza na fone sakharnogo diabeta. Mat-ly VII Vseross. diabetologicheskogo kongr. 2015; 1: 32 (in Russ.)].
  22. Марьехина О.А., Мордык А.В., Плеханова М.А. и др. Влияние сахарного диабета на клинические проявления, течение и результаты лечения туберкулеза. Сибирское медицинское обозрение. 2011; 2: 78–80 [Mordyk A.V., Plekhanova M.A., Sitnikova S.V. Diabetes influences on clinical symptoms, disease course and treatment results in patients with tuberculosis. Siberian Medical Review. 2011; 2: 78–80 (in Russ.)].
  23. Magee M.J., Kempker R.R., Kipiani M. et al. Diabetes mellitus is associated with cavities, smear grade, and multidrug-resistant tuberculosis in Georgia. Int J Tuberc Lung Dis. 2015; 19 (6): 685–92. doi: 10.5588/ijtld.14.0811
  24. Jabbar A., Hussain S.F., Khan A.A. Clinical characteristics of pulmonary tuberculosis in adult Pakistani patients with co-existing diabetes mellitus. East Mediterr Health J. 2006; 12 (5): 523–7.
  25. Tatar D., Senol G., Alptekin S. et al. Tuberculosis in diabetics: features in an endemic area. Jpn J Infect Dis. 2009; 62: 423–7.
  26. Singla R., Khan N., Al-Sharif N. et al. Influence of diabetes on manifestations and treatment outcome of pulmonary TB patients. Int J Tuberc Lung Dis. 2006; 10: 74–9.
  27. Perez-Guzman C., Torres-Cruz A., Villarreal-Velarde H. et al. Atypical radiological images of pulmonary tuberculosis in 192 diabetic patients: a comparative study. Int J Tuberc Lung Dis. 2001; 5: 455–61.
  28. Yoon Y.S., Jung J.W., Jeon E.J. et al. The effect of diabetes control status on treatment response in pulmonary tuberculosis: a prospective study. Thorax. 2016; 72 (3): 263–70. doi: 10.1136/thoraxjnl-2015-207686
  29. Комиссарова О.Г., Абдуллаев Р.Ю., Алешина С.В. и др. Туберкулез легких у больных с разными типами сахарного диабета: течение и эффективность лечения. Уральский медицинский журнал. 2018; 8: 53–8 [Komissarova O.G., Abdullaev R.Yu., Aleshina S.V. et al. Pulmonary tuberculosis in patients with different types of diabetes mellitus: course and efficacy of treatment. Ural Medical Journal. 2018; 8: 53–8 (in Russ.)]. doi: 10.25694/URMJ.2018.05.51
  30. Комиссарова О.Г., Абдуллаев Р.Ю. Туберкулемы легких у больных с сопутствующим сахарным диабетом. Туберкулез и болезни легких. 2017; 95 (11): 51–4 [Komissаrovа O.G., Аbdullаev R.Yu. Pulmonary tuberculomas in diabetes patients. Tuberculosis and Lung Diseases. 2017; 95 (11): 51–4 (in Russ.)]. doi: 10.21292/2075-1230-2017-95-11-51-54
  31. Zhang Q., Xiao H., Sugawara I. Tuberculosis complicated by Diabetes Mellitus of Shanghai Pulmonary Hospital, China. Jpn Infect Dis. 2009; 62: 390–1.
  32. Baldé N.M., Camara A., Camara L. M. et al. Associated tuberculosis and diabetes in Conakry, Guinea: Prevalence and clinical characteristics. Int J Tuberc Lung Dis. 2006; 10 (9):1036–40.
  33. Alisjahbana B., van Crevel R., Sahiratmadja E. et al. The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis. Clin Infect Dis. 2007; 45 (4): 428–35. doi: 10.1086/519841
  34. Costa J.C., Gomes M., Duarte R. Diabetes mellitus and pulmonary tuberculosis. Portuguese retrospective cohort. Eur Resp Dis. 2015; 46 (suppl 59): PA2723. doi: 10.1183/13993003.congress-2015.PA2723
  35. Koesoemadinata R.C., McAllister S.M., Soetedjo N.N.M. et al. Diabetes characteristics and long-term management needs in diabetic TB patients. Int J Tuberc Lung Dis. 2023; 27 (2): 113–20. doi: 10.5588/ijtld.22.0367
  36. Chiang C.Y., Bai K.J., Lin H.H. et al. The Influence of Diabetes, Glycemic Control, and Diabetes-Related Comorbidities on Pulmonary Tuberculosis. PLoS One. 2015; 10 (3): 1–15. doi: 10.1371/journal.pone.0121698
  37. Jimenez-Corona M.E., Cruz-Hervert L.P., Garcia-Garcia L. et al. Association of diabetes and tuberculosis: impact on treamtent and post-treatment outcomes. Thorax. 2013; 68: 214–20. doi: 10.1136/thoraxjnl-2012-201756
  38. Папенова Е.А., Одинец В.С., Задремайлова Т.А. и др. Влияние раннего выявления туберкулеза органов дыхания у больных сахарным диабетом на эффективность лечения в Ставропольском крае. Туберкулез и болезни легких. 2015; 7: 109–10 [Papenova E.A., Odinets V.S., Zadremailova T.A. et al. Impact of early detection of respiratory tuberculosis in diabetic patients on the effectiveness of treatment in Stavropol Region. Tuberculosis and Lung Diseases. 2015; 7: 109–10 (in Russ.)].
  39. Restrepo B.I. Diabetes and tuberculosis. Microbiol Spectrum. 2016; 4 (6): 1–11. doi: 10.1128/microbiolspec.TNMI7-0023-2016
  40. Турдумамбетова Г.К. Химиотерапия туберкулеза легких у больных сахарным диабетом. Здравоохранение Кыргызстана. 2013; 1: 31–4 [Turdumambetova G.K. Chemotherapy of respiratory tuberculosis in diabetes mellitus patients. Health Care of Kyrgyzstan. 2013; 1: 31–4 (in Russ.)].
  41. Chiang C.Y., Lee J.J., Yu M.C. et al. Tuberculosis outcomes in Taipei: factors associated with treatment interruption for 2 months and death. Int J Tuberc Lung Dis. 2009; 13: 105–11.
  42. Park S.W., Shin J.W., Kim J.Y. et al. The effect of diabetic control status on the clinical features of pulmonary tuberculosis. Eur J Clin Microbiol Infect Dis. 2012; 31: 1305–10. doi: 10.1007/s10096-011-1443-3
  43. Riza A.L., Pearson F., Ugarte-Gil C. и др. Clinical management of concurrent diabetes and tuberculosis and the Implications for Patient Services. Lancet Diabetes Endocrinol. 2016; 2 (9): 740–53. doi: 10.1016/S2213-8587(14)70110-X
  44. Rekha V.B., Balasubramanian R., Swaminathan S. et al. Sputum conversion at the end of intensive phase of Category-1 regimen in the treatment of pulmonary tuberculosis patients with diabetes mellitus or HIV infection: An analysis of risk factors. Indian J Med Res. 2007; 126 (5): 452–8.
  45. Wu Z., Guo J., Huang Y. et al. Impact of diabetes mellitus on clinical presentation and treatment outcome of pulmonary tuberculosis in an urban area in China. Int J Tuberc Lung Dis. 2014; 18 (Suppl. 1): S240.
  46. Baltas I., Sturdy A., Kavallieros K. et al. Diabetes mellitus is not a predictor of poor TB treatment outcomes. Int J Tuberc Lung Dis. 2023; 27 (2): 140–5. doi: 10.5588/ijtld.22.0470
  47. Siddiqui A.N., Khayyam K.U., Sharma M. Effect of Diabetes Mellitus on Tuberculosis Treatment Outcome and Adverse Reactions in Patients Receiving Directly Observed Treatment Strategy in India: A Prospective Study. Biomed Res Int. 2016; 2016: 1–11. doi: 10.1155/2016/7273935
  48. Ayeni F.A., Oyetunde O.O., Aina B.A. The effect of collaborative care on treatment outcomes of newly diagnosed tuberculosis patients with Type-2 diabetes mellitus and adverse drug reaction presentations: A prospective study. Int J Mycobacteriol. 2021; 10 (3): 285–92. doi: 10.4103/ijmy.ijmy_124_21
  49. Agyeman A.A., Ofori-Asenso R. Efficacy and safety profile of linezolid in the treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis: A systematic review and meta-analysis. Ann Clin Microbiol Antimicrob BioMed Central. 2016; 15 (1): 1–17. doi: 10.1186/s12941-016-0156-y
  50. Muñoz-Torrico M., Caminero-Lunab J., Migliori G.B. et al. Diabetes is Associated with Severe Adverse Events in Multidrug-Resistant Tuberculosis. Arch Bronconeumol. 2017; 53 (5): 245–50. doi: 10.1016/j.arbres.2016.10.021
  51. Комиссарова О.Г., Абдуллаев Р.Ю., Алешина С.В. Частота и характер нежелательных реакций на противотуберкулезные препараты у больных туберкулезом легких и сахарным диабетом. Туберкулез и болезни легких. 2020; 98 (2): 10–4 [Komissarova O.G., Аbdullaev R.Yu., Aleshina S.V. Frequency and characteristics of adverse events caused by anti-tuberculosis drugs in pulmonary tuberculosis patients with diabetes myelitis. Tuberculosis and Lung Diseases. 2020; 98 (2): 10–1 (in Russ.)]. doi: 10.21292/2075-1230-2020-98-2-10-14
  52. Collaborative framework for care and control of tuberculosis and diabetes. Geneva: World Health Organization, 201. URL: https://apps.who.int/iris/bitstream/handle/10665/44698/9789241502252eng.pdf
  53. Reducing the burden of noncommunicable diseases through strengthening prevention and control of diabetes, Seventy-fourth World Health Assembly. A74/A/CONF./5 Agenda item 13.2, 24 May 2021. Geneva: World Health Assembly, 2021. URL: https://apps.who.int/gb/ebwha/pdf_files/WHA74/A74_R4-en.pdf

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies